Crossmark

Toll-like receptor 9 agonists and combination therapies: strategies to modulate the tumour immune microenvironment for systemic anti-tumour immunity

Published Online: 2022-07-28

Published Print: 2022-11-01

Authors

Dongye, Zhangchi

Li, Jian http://orcid.org/0000-0003-0212-4464
Wu, Yuzhang
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (32070912, 32070912)

National Key Research and Development Program of China
License Information

Text and Data Mining valid from 2022-07-28

Version of Record valid from 2022-07-28
More Information

Article History

Received: 13 March 2022

Revised: 11 May 2022

Accepted: 31 May 2022

First Online: 28 July 2022

Competing interests

: The authors declare no competing interests.

Free to read: This content has been made available to all.

Document is current